Catalog No.
Product Name
Application
Product Information
Citations
-
BRD 4/p38α/BRDT Inhibitor
SB-284851-BT is a selective inhibitor of BRD4, p38α, and BRDT. It effectively inhibits BRD4-BD1 with an IC50 of 1.7 µM, p38α with a Kd of 0.47 nM, and exhibits additional inhibitory activity against BRDT and BRD4 with IC50 values of 18 µM and 3.7 µM, respectively. SB-284851-BT significantly reduces IL-8 production through p38α inhibition and downregulates crucial oncogenic pathways such as c-Myc and NF-κB via BRD4 inhibition. This compound has potential applications in cancer research and therapeutic development targeting cellular signaling pathways. -
BRD4 BD1 Inhibitor
ZL0516 is a selective inhibitor of the BRD4 bromodomain 1 (BD1), demonstrating potent activity in modulating epigenetic regulation. It effectively suppresses inflammatory bowel disease (IBD) through inhibition of the BRD4/NF-κB signaling pathway, which plays a critical role in inflammation and immune responses. This compound is primarily utilized in research focusing on the development of therapeutic strategies for IBD and related inflammatory conditions. -
Inflammatory Pathway Inhibitor, Oxidative Stress Inhibitor, Cancer Pathway Inhibitor
Matairesinol is an orally active bioactive compound that functions as an inflammatory pathway, oxidative stress, and cancer pathway inhibitor. It effectively inhibits the phosphorylation of MAPK, JNK, and NF-κB, while downregulating RANKL-induced NFATc1 expression and activity, and suppressing the activation of the PI3K/AKT/FOXO1 pathway. Matairesinol is applicable in research on sepsis-mediated brain injury, osteoporosis, heart failure, atopic dermatitis, and various cancer models. -
AMPK Activator
IMM-H007 is a potent AMPK (AMP-activated protein kinase) activator and TGFβ1 (transforming growth factor β1) antagonist. This compound exhibits cardioprotective effects by activating AMPK, which subsequently reduces endothelial inflammation through the inactivation of NF-κB and JNK/AP1 signaling pathways. Additionally, IMM-H007 regulates lipid metabolism, effectively resolving hepatic steatosis in high-fat diet-fed hamsters. It is suitable for research applications focused on nonalcoholic fatty liver disease (NAFLD) and inflammatory atherosclerosis. -
JNK Inhibitor
Salicortin is a phenolic glycoside that functions as a JNK inhibitor. It effectively inhibits osteoclast differentiation and bone resorption by down-regulating the JNK and NF-κB/NFATc1 signaling pathways. Salicortin exhibits a range of biological activities, including anti-amnesic, anti-adipogenic, and immune-modulatory effects, making it a valuable tool for research in bone metabolism, neurobiology, and immunology. -
NF-κB Inhibitor
Esculentoside H (EsH) is a saponin with inhibitory effects on the NF-κB signaling pathway. It exhibits notable anti-tumor activity, primarily through the modulation of TNF release. EsH has been shown to suppress colon cancer cell migration by inhibiting JNK1/2 and reducing the expression of matrix metalloproteinases-9 (MMP-9), making it a valuable tool for research in cancer biology and therapeutic interventions. -
NF-κB/AP-1 Inhibitor
IQ-1S is an inhibitor of NF-κB and activating protein 1 (AP-1), exhibiting an IC50 of 1.8 μM. It demonstrates significant binding affinity for all three JNK isoforms, with Kd values of 87 nM for JNK3, 360 nM for JNK2, and 390 nM for JNK1. IQ-1S is valuable for researchers investigating the role of JNK signaling pathways and their implications in inflammation and cancer. -
JNK2 Inhibitor
JNK2-IN-1 is a selective inhibitor of JNK2, displaying a dissociation constant (Kd) of 79.2 μM. This compound exhibits anti-inflammatory properties by reducing the secretion of pro-inflammatory cytokines TNF-α and IL-6 through the inhibition of the NF-κB/MAPK signaling pathway. JNK2-IN-1 has demonstrated therapeutic potential in alleviating symptoms associated with LPS-induced acute lung injury (ALI) and sepsis, making it valuable for research in inflammation and related diseases. -
Rare Sugar
D-Psicose is a rare sugar that exhibits its biological activity primarily through the inhibition of p38 MAPK phosphorylation and MCP-1 expression. It effectively targets the AGEs/RAGE/NF-κB signaling pathway, offering protective effects on pancreatic β-islets. Additionally, D-psicose has been shown to improve hyperglycemia and mitigate high-fat diet-induced non-alcoholic fatty liver disease, making it a valuable reagent for research in metabolic disorders and diabetes. -
NF-κB p65 Inhibitor, p38 MAPK Inhibitor
PSMα3 is an inhibitor of NF-κB p65 and p38 MAPK, playing a significant role in modulating inflammatory pathways. This compound forms membrane pores and interacts with the human insulin B chain, inhibiting insulin aggregation and contributing to cytotoxic effects through α-type amyloid-like fibril formation. PSMα3 is valuable for research on spondyloarthritis, rheumatoid arthritis, insulin-derived amyloidosis, and infections caused by Staphylococcus aureus. -
NF-κB/MAPK Inhibitor
NF-κB/MAPK-IN-1 is a potent inhibitor of the NF-κB and MAPK signaling pathways, exhibiting significant biological activity in the modulation of inflammatory responses. It effectively reduces nitric oxide (NO) production with an IC50 of 6.96 µM and inhibits the activation of iNOS, COX-2, ERK, and p38 signaling pathways induced by LPS. This compound is valuable for research applications focused on inflammatory diseases, including rheumatoid arthritis. -
NF-κB/MMP9/MAPK Inhibitor
Isoliquiritin apioside is an inhibitor of NF-κB, MMP9, and MAPK signaling pathways. It has been shown to significantly reduce PMA-induced MMP9 activity and suppress the activation of MAPK and NF-κB. This compound is relevant for research applications focused on cancer biology, particularly in the investigation of mechanisms underlying cell invasiveness and angiogenesis in both cancer and endothelial cells. -
Stable Isotope
D-Psicose-d is a deuterium-labeled form of D-Psicose, which serves as a stable isotope for research applications. This rare sugar is known for its oral bioactivity and demonstrates inhibitory effects on p38-MAPK phosphorylation and MCP-1 expression. D-Psicose also modulates the AGEs/RAGE/NF-κB signaling pathway, offering protective effects on pancreatic β-islets and improving metabolic conditions such as hyperglycemia and non-alcoholic fatty liver disease induced by high-fat diets. -
Stable Isotope
Fumaric acid-13C2 is a stable isotope-labeled version of fumaric acid, an unsaturated dicarboxylic acid involved in the citric acid cycle. This compound plays a critical role in energy metabolism by facilitating ATP production. Additionally, fumaric acid exhibits anti-inflammatory properties by inhibiting the NF-κB signaling pathway via p38 MAPK modulation. Its applications extend to the investigation of conditions such as pregnancy-induced hypertension, making it a valuable tool for metabolic and physiological research. -
IRAK4 Inhibitor
UR241-2 is a selective inhibitor of IRAK4, targeting the IL-1–induced IRAK1/4 signaling pathway. It effectively suppresses NF-κB activation and the phosphorylation of p65 and p38, contributing to a reduction in leukemia stem cell clonogenicity. UR241-2 also serves as a valuable ligand for developing PROTAC degraders targeting IRAK4, making it a suitable tool for research in acute myeloid leukemia. -
Diterpenoid Quinone
Dehydromiltirone is a diterpenoid quinone that exhibits significant anti-inflammatory properties. It modulates the MAPK and NF-κB signaling pathways, thereby preventing liver injury and reducing neuroinflammatory responses. Additionally, Dehydromiltirone has been shown to inhibit platelet aggregation and is relevant for research applications in osteoporosis. -
Sea Green Triarylmethane Food Dye
Fast Green FCF is a sea green triarylmethane food dye known for its absorption maximum between 622 and 626 nm. This compound exhibits inhibitory effects on α-synuclein aggregation, the amyloid beta (Aβ) peptide, P2X4 receptors, and the TLR4/Myd88/NF-κB signaling pathway. Fast Green FCF is utilized as a quantitative stain for histones at alkaline pH following acid extraction of DNA, as well as a protein stain in electrophoresis applications. Additionally, it has shown potential benefits in addressing cognitive impairment, mood disorders, pain allergies, and reproductive function. -
Fluoresce Localization Anti-GBM Agent
IR-Crizotinib is a near-infrared dye-conjugated NF-κB-inducing kinase (NIK) inhibitor that effectively crosses the blood-brain barrier. This compound demonstrates selective fluorescent localization in intracranial glioblastoma (GBM) models, with an IC50 of 3.381 μM. In addition to its fluorescent capabilities, IR-Crizotinib inhibits growth and invasion of glioma cells both in vitro and in vivo, making it a valuable tool for cancer research and therapeutic development. -
Sea Green Triarylmethane Food Dye
Fast Green FCF free acid is a triarylmethane food dye known for its acid resistance. It exhibits significant biological activity by inhibiting α-synuclein aggregation, as well as interfering with Aβ, P2X4 receptor, and TLR4/Myd88/NF-κB signaling pathways. This reagent is extensively utilized as a quantitative stain for histones under alkaline conditions following DNA acid extraction, and it serves as a protein stain in electrophoresis applications. Additionally, Fast Green FCF free acid has been implicated in enhancing cognitive function, alleviating depression, mitigating pain allergies, and supporting reproductive health. -
TRPA1 Inhibitor
Aurothiomalate disodium acts as a TRPA1 inhibitor, effectively blocking NF-κB activation and inhibiting iNOS expression. This compound fosters the M2 transformation of macrophages and enhances the expression of TREM-2 and arginase-1. Aurothiomalate disodium is applicable in research concerning liver fibrosis, cirrhosis, and arthritis, providing insights into inflammation and tissue repair mechanisms. -
Alkaloid
β-Carboline-1-carboxylic acid is a β-carboline alkaloid that acts as an inhibitor of phosphodiesterase and indoleamine 2,3-dioxygenase, demonstrating an IC50 of 96 µM for cAMP phosphodiesterase. It exhibits significant biological activities including anti-inflammatory, antifibrotic, antitumor, and antibacterial properties, with cytotoxic effects on tumor cells. Furthermore, this compound inhibits inflammation via the NF-κB/p65 pathway and reverses epithelial-mesenchymal transition (EMT). It also shows potent antibacterial effects against Staphylococcus aureus and Escherichia coli, with IC50 values of 47.70 μg/mL and 19.17 μg/mL, respectively. -
LUBAC Inhibitor
HOIPIN-8 is a highly potent inhibitor of the linear ubiquitin chain assembly complex (LUBAC), exhibiting an IC50 value of 11 nM. As a derivative of HOIPIN-1, it offers significantly enhanced inhibition, demonstrating a 255-fold increase in potency for petit-LUBAC, along with 10-fold and 4-fold increases in inhibiting LUBAC and TNF-α-mediated NF-κB activation, respectively. HOIPIN-8 serves as an essential research tool for investigating the cellular functions of LUBAC and its role in various biological processes. -
NF-κB Degrader
EN450 is a cysteine-reactive covalent molecular glue degrader targeting NF-κB. By engaging with allosteric C111 in the E2 ubiquitin ligase UBE2D, EN450 facilitates the formation of a ternary complex involving UBE2D and NFKB1. This interaction leads to the degradation of NF-κB, resulting in notable anti-proliferative effects through a Cullin E3 ligase and proteasome-dependent mechanism. EN450 serves as a valuable tool for research involving NF-κB signaling and its implications in cancer biology. -
Anti-inflammatory agent
Hentriacontane is a long-chain alkane that acts as an anti-inflammatory agent by inhibiting the NF-κB signaling pathway. Its bioactivity encompasses not only anti-inflammatory effects but also antitumor and antibacterial properties. This compound is valuable for research applications focused on inflammation modulation, cancer biology, and antimicrobial studies. -
Colistin Adjuvant
Colistin adjuvant-1 is a potent colistin adjuvant that enhances the activity of colistin against Gram-negative bacteria. It functions primarily by inhibiting NF-κB, exhibiting an IC50 of 0.209 μM. This compound is valuable for research applications aimed at combating antibiotic resistance and investigating combination therapies in bacterial infections. -
Na+/K+-ATPase Inhibitor
(-)-γ-Cuparenol is a sesquiterpene compound that acts as an inhibitor of Na+/K+-ATPase, with an IC50 value of 23.6 μg/mL in porcine models. It has demonstrated the ability to reduce phytohemagglutinin (PHA)-induced activation of NF-AT and NF-κB in Jurkat cells, indicating potential applications in immunoregulation. Additionally, (-)-γ-Cuparenol exhibits antibacterial activity against certain Gram-positive and some Gram-negative bacteria, as well as weak inhibitory effects on Candida albicans. This compound is relevant for research exploring cardiovascular diseases and bacterial infections. -
Antibiotic
Epoxyquinomicin C is an antibiotic derived from the soil bacterium Amycolatopsis sp. It displays anti-inflammatory properties, particularly in models of collagen-induced arthritis, making it a valuable tool for studying inflammatory pathways. Additionally, Epoxyquinomicin C serves as a synthetic precursor for the NF-κB inhibitor DHMEQ, facilitating research into therapeutic applications targeting NF-κB signaling. -
Flavouring Agent
Vanillic acid is a flavoring agent primarily derived from various edible plants and fruits, including Angelica sinensis. It is known to inhibit the activation of NF-κB, contributing to its anti-inflammatory and antibacterial properties. Additionally, vanillic acid exhibits chemopreventive effects, making it a valuable compound for research in inflammation and cancer prevention studies. -
Bacterial Inhibitor/Anti-inflammatory Agent
Cyclo(L-Pro-L-Val) is a peptide-based compound that functions as a bacterial inhibitor and anti-inflammatory agent. It exhibits antimicrobial activity against plant pathogens, such as R. fascians, and demonstrates significant inhibition of critical signaling molecules like IKKα, IKKβ, NF-κB, iNOS, and COX-2, contributing to its anti-inflammatory properties. This compound is valuable for research applications in developing biopesticides and investigating inflammation-related diseases. -
Organic Ketone
2-Undecanone is an organic ketone that exhibits antibacterial properties by inhibiting bacterial chaperone systems, thereby disrupting the refolding process of heat-inactivated proteins. Additionally, it mitigates asthmatic inflammation and airway remodeling through blockade of the NF-κB pathway, while activating the Nrf2 pathway to reduce oxidative damage and offer protection against lung cancer induced by Benzo[a]pyrene. This compound is relevant for research into cancer, asthma, and infectious diseases. -
Anti-Aging/Anti-Cancer Agent
8-O-Acetylharpagide is an iridoid glycoside compound that primarily targets anti-aging and anti-cancer pathways. At low doses, it demonstrates significant anti-aging properties, while high doses induce apoptosis and necrosis in cancer cells, effectively downregulating anti-apoptotic proteins such as Akt, p-Akt, and Bcl-2. Metabolism studies indicate that 8-O-acetylharpagide undergoes processes like demethylation, hydrolysis, and glucuronidation in rats, leading to the formation of active metabolites that attenuate the AKT/NF-κB/MMP9 signaling axis. Additionally, it exerts vasoconstrictive effects through the activation of vascular α-adrenoceptors, further contributing to its biological activity. -
Anti-inflammatory Agent
Scutellarein tetramethyl ether (4',5,6,7-Tetramethoxyflavone) primarily functions as an anti-inflammatory agent. This bioactive compound, derived from Eupatorium odoratum, demonstrates significant anti-inflammatory, antibacterial, pro-coagulant, and anti-tumor properties. It modulates the NF-κB signaling pathway to exert its anti-inflammatory effects and enhances coagulation time through the endogenous coagulation pathway. Additionally, Scutellarein tetramethyl ether has been shown to inhibit the proliferation of HepG2 liver cancer cells, with an IC50 value of 20.08 μg/mL, making it relevant for cancer research and therapeutic studies. -
TrxR1 Inhibitor
Evernic Acid is a potent inhibitor of thioredoxin reductase 1 (TrxR1), demonstrating significant antiproliferative effects on human breast cancer cells. It disrupts the NF-κB signaling pathway by preventing p65 nuclear translocation and IκBα phosphorylation, which subsequently reduces inflammatory mediators. In addition to its role as an antioxidant and neuroprotective agent, Evernic Acid protects neurons from oxidative stress and mitochondrial dysfunction. Furthermore, it inhibits key enoyl reductases in Plasmodium falciparum and downregulates quorum sensing and biofilm formation in Pseudomonas aeruginosa, showcasing its antibacterial and antifungal properties. This compound is valuable for research focused on breast cancer, neurodegenerative diseases, and microbial infections. -
Antibiotic Agent
Cloxacillin sodium is a β-lactam antibiotic and a potent β-lactamase inhibitor with an IC50 of 0.04 µM. It exhibits significant antibacterial activity, particularly against Staphylococcus aureus, and can effectively attenuate the S. aureus-induced inflammatory response by inhibiting the activation of MAPK, NF-κB, and NLRP3-related proteins. This compound is relevant for research in antimicrobial resistance and inflammation pathways. -
Antibiotic
Streptazolin is an antibiotic that enhances bacterial clearance and promotes the secretion of immunostimulatory cytokines by macrophages in vitro. It activates the macrophage NF-κB pathway through the PI3K signaling cascade, contributing to its immunomodulatory effects. This compound is valuable for research applications aimed at understanding antibiotic efficacy and macrophage behavior in immune responses. -
Antibacterial Agent
Cloxacillin is an orally active antibacterial agent and β-lactamase inhibitor, exhibiting an IC50 of 0.04 µM. It effectively suppresses the inflammatory response induced by Staphylococcus aureus by inhibiting the activation of mitogen-activated protein kinases (MAPKs), nuclear factor kappa B (NF-κB), and proteins associated with the NLRP3 inflammasome. This compound is useful for research applications focused on bacterial infections and inflammatory processes. -
Sesquiterpene
Terrecyclic Acid is a sesquiterpene derived from the fungal species Aspergillus terreus. This compound exhibits notable antibiotic and anticancer properties, demonstrating activity against Staphylococcus aureus, Bacillus subtilis, and Micromonospora roseus with minimum inhibitory concentrations of 25, 50, and 25 μg/mL, respectively. Additionally, terrecyclic acid induces a heat shock response, elevates reactive oxygen species (ROS) levels, and suppresses NF-κB activity and cellular proliferation in 3T3-Y9-B12 cells. In vivo studies reveal that terrecyclic acid effectively reduces ascitic fluid tumor cell counts in a mouse model of P388 murine leukemia at concentrations of 0.1, 1, and 10 mg/mL. -
TPA Negative Control
4α-TPA is an inactive analog of TPA, serving as a negative control in TPA-mediated experiments. This reagent is critical for distinguishing specific TPA-activated events from non-specific responses in biological assays. It aids researchers in validating experimental outcomes related to TPA signaling pathways and discerning the effects of TPA on various cellular processes. -
PKC Inhibitor
PKC-IN-4 is a selective inhibitor of atypical protein kinase C (aPKC) with an IC50 of 0.52 µM. This compound effectively inhibits TNF-α-induced NF-κB signaling in vitro, making it a valuable tool for studies involving inflammatory responses. Additionally, PKC-IN-4 has been shown to block VEGF- and TNF-α-induced permeability across the retinal vasculature, highlighting its potential in retinal disease research and vascular permeability exploration. -
Survivin Inhibitor
Isonanangenine B is a selective inhibitor of survivin, exhibiting an IC50 of 1.6 µM. It effectively obstructs the interaction of critical transcription factors, including Stat3 and NF-κB, with the survivin promoter. This compound holds potential for advancing cancer research, particularly in elucidating the mechanisms of survivin modulation in tumorigenesis. -
Doxorubicin Glycoside Ligand
Doxorubicinone is the aglycone form of the anthracycline antibiotic Doxorubicin, functioning primarily as a Doxorubicin glycoside ligand. It exhibits notable anti-inflammatory activity by downregulating the expression of pro-inflammatory cytokines, including TNF and IL-12, through modulation of the NF-κB signaling pathway. Doxorubicinone is particularly useful in research related to sepsis and other inflammatory conditions, providing insights into cytokine regulation without inducing DNA damage. -
TNF-α/NF-κB Inhibitor
TNF-α-IN-28 is a selective inhibitor of TNF-α and NF-κB, demonstrating significant anti-inflammatory activity. This compound effectively inhibits the expression of both TNF-α and NF-κB by targeting the TNF-α dimer. TNF-α-IN-28 is intended for use in research applications focused on inflammation, immune response modulation, and related signaling pathways. -
CDK8/19 Inhibitor
Senexin A hydrochloride is a selective inhibitor of cyclin-dependent kinases 8 and 19 (CDK8 and CDK19), with an IC50 of 280 nM for CDK8. It specifically targets and inhibits p21-induced transcription, while sparing other biological functions of p21. In addition, Senexin A hydrochloride effectively suppresses CMV-GFP induction and the p21 stimulatory activity of NF-κB-dependent promoters, making it a valuable tool for studying transcriptional regulation and cell signaling pathways. -
CDK8 Inhibitor
CDK8-IN-15 is a selective inhibitor of cyclin-dependent kinase 8 (CDK8), exhibiting a potent IC50 of 57 nM. This compound enhances the thermal stability of CDK8 while effectively inhibiting NF-κB signaling pathways. CDK8-IN-15 demonstrates promising biological activity in an in vitro psoriasis model induced by TNF-α, alleviating inflammation and promoting the expression of anti-inflammatory markers such as Foxp3 and IL-10. This makes it a valuable tool for research into psoriasis and related inflammatory disorders. -
CTH/H2S/NF-κB/EMT Inhibitor
TKL002 is a selective inhibitor targeting the CTH/H2S/NF-κB/EMT signaling pathway, proven to penetrate the blood-brain barrier. It effectively induces G2/M phase cell cycle arrest and apoptosis in glioblastoma cells, simultaneously inhibiting their migration and invasion. This compound upregulates E-cadherin while downregulating N-cadherin and vimentin, making it a valuable tool for investigative studies in glioblastoma research. -
Survivin Inhibitor
MX107 is a selective survivin inhibitor known for its potent efficacy in suppressing the proliferation of triple-negative breast cancer (TNBC) cells. By inducing the degradation of survivin and inhibitor-of-apoptosis proteins (IAPs), MX107 effectively inhibits nuclear factor κB (NF-κB) activation in response to DNA damage. This compound enhances the tumoricidal effects of genotoxic treatments when used in conjunction with chemotherapeutic agents, making it a valuable tool in cancer research and therapy development. -
RIPK2 Inhibitor
CSLP43 is a selective inhibitor of RIPK2, demonstrating an IC50 of 19.9 nM against human RIPK2. By binding to the ATP-binding pocket of RIPK2, CSLP43 disrupts its interaction with the BIR2 domain of XIAP and cIAP1, effectively inhibiting RIPK2 ubiquitination and regulating NOD1- and NOD2-dependent inflammatory signaling pathways, as well as NF-κB activation. This compound is particularly relevant for research investigating Crohn's disease, Blau syndrome, early-onset sarcoidosis, and early-onset inflammatory bowel disease, due to its selectivity for the NOD1/NOD2 signaling pathway without affecting RIPK1 or RIPK3 activity. -
NF-κB Inhibitor/p53 Activator
CBLC100 is an NF-κB inhibitor and a p53 activator that exhibits potent anticancer properties. By targeting FACT, CBLC100 induces cytotoxicity through both p53-dependent apoptotic and non-apoptotic pathways. This compound is particularly relevant for research applications centered on cancers, including fibrosarcoma, making it a valuable tool for studying tumorigenesis and therapeutic responses. -
p53-MDM2 Inhibitor
p53-MDM2-IN-2 is an orally active inhibitor targeting the p53-MDM2 interaction, exhibiting a Ki value of 0.25 μM. This compound demonstrates antitumor activity through the inhibition of the NF-κB signaling pathway. It is valuable in research studies focusing on cancer therapy and elucidating the molecular mechanisms of tumor suppression. -
p53-MDM2 Inhibitor
p53-MDM2-IN-3 is a potent p53-MDM2 inhibitor with a Ki value of 0.25 μM, demonstrating oral bioavailability. This compound exhibits significant antitumor activity through its inhibition of the NF-κB signaling pathway. It serves as a valuable tool for cancer research, particularly in studies focused on targeting the p53-MDM2 interaction and the subsequent effects on tumor proliferation and survival.
